Question: why are pharmaceutical companies reluctant to develop new antibiotics?
Answer: A scientific breakthrough doesn't guarantee success though, as much more funding is needed to see drugs through the expensive process of clinical trials, registration and coming to market. Once companies lose early-stage funding, it becomes much more difficult to find investment.